Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.85 EUR | +0.79% | -2.53% | +37.62% |
Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 85.00 | 85.00 | 85.00 |
Spread/Res. | -2.53% | -2.53% | -2.53% |
Spread/Supp. | +1.53% | +35.49% | +45.99% |
Support | 81.60 | 61.15 | 56.75 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.